Cite
MLA Citation
A.J. Moskowitz et al.. “BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET‐ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE.” Hematological oncology, vol. 35, n.d., pp. 36–37. http://access.bl.uk/ark:/81055/vdc_100047474190.0x000026